Isolation and expression of farnesene synthase from peppermint, mentha x piperita, l.
CA 2305629 A1 · Owner: Crock, John E. · Inventors: Crock, John E.; Croteau, Rodney B.; Wildung, Mark R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A cDNA encoding (E)-.beta.-farnesene synthase from peppermint (Mentha piperita) has been isolated and sequenced and the corresponding amino acid , sequence has been determined. Accordingly an isolated DNA sequence (SEQ ID , NO:1) is provided which codes for the expression of (E)-.beta.-farnesene synthase (SEQ ID NO:2), from peppermint (Mentha piperita). In other aspects replicable recombinant cloning vehicles are provided which code for (E)-.beta.farnesene synthase, or for base sequence sufficiently complementary to at least a portion of (E)-.beta.-farnesene synthase DNA or RNA to enable hybridization therewith. In yet other aspects modified host cells are , provided that have been …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 5, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 5, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 5, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.